EN HU

Katona Éva

Katona Éva

Publication list

Uploaded publications:
100
Publications in DEA:
99
OA:
29
Date range:
1987-2026
2026
1.
Marchi, R., Katona, É., Durual, S., Demaistre, E., Savard, P., Casini, A.: The Hypofibrinolysis State Associated with the Dysfibrinogenemia Dusart is Mainly Related to the Altered Fibrin Clot Structure.
Hamostaseologie [Epub ahead of print], 2026.
Journal metrics:
Q2 Hematology (2024)
2025
2.
Uj, E. A., Molnár, É., Miklós, T., Gindele, R., Shemirani, A. H., Bereczky, Z., Katona, É.: Beta-Antithrombin Levels in Patients with Venous Thromboembolism.
Int. J. Mol. Sci. 26 (22), 1-13, (article identifier: 11151), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
3.
Bagoly, Z., Tóth, E. L., Orbán-Kálmándi, R. A., Lóczi, L., Deli, T., Török, O., Kozma, B., Baráth, S., Singh, P., Hevessy, Z., Tóth, J., Katona, É., Molnár, S., Krasznai, Z. T.: Complex evaluation of coagulation, fibrinolysis, and inflammatory cytokines in SARS-CoV-2 infected pregnant women: a prospective, case-control study.
Front. Immunol. 16, 1-18, (article identifier: 1556878), 2025.
Journal metrics:
Q1 Immunology (2024)
Q1 Immunology and Allergy (2024)
4.
Kissné Bogáti, R., Baráth, B., Pituk, D., Orbán-Kálmándi, R. A., Szűcs, P., Hegyi, Z., Bereczky, Z., Bagoly, Z., Katona, É.: Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure.
Biomolecules. 15 (8), 1-16, (article identifier: 1127), 2025.
Journal metrics:
Q1 Biochemistry (2024)
Q2 Molecular Biology (2024)
5.
Martos, R., Harangi, M., Szabó, J., Földvári, A., Sándor, J., Katona, É., Tar, I., Paragh, G., Kiss, C., Márton, I.: Effects of Combined Periodontal, Endodontic, and Dentoalveolar Surgical Treatments on Laboratory Parameters in Patients with Hyperlipidemia: A Clinical Interventional Study.
J Clin Med. 14 (1), 1-16, (article identifier: 241), 2025.
Journal metrics:
Q1 Medicine (miscellaneous) (2024)
6.
Ding, Y., Potor, L., Katona, É., Sótonyi, P., Szappanos, Á., Gyurok, G. P., Méhes, G., Hendrik, Z., Fintha, A., Gergely, P., Benyó, Z., Combi, Z., Sikura, K. É., Beke, L., Németh, N., Szabó, B., Fürtös, I., Kalló, G., Csősz, É., Póliska, S., Patsalos, A., Debus, E. S., Nagy, L., Balla, G., Balla, J.: Oxidation of hemoglobin to ferryl hemoglobin contributes to remodeling of the artery wall in abdominal aortic aneurysm.
Redox Biol. 88, 1-19, (article identifier: 103908), 2025.
Journal metrics:
D1 Biochemistry (2024)
D1 Clinical Biochemistry (2024)
D1 Organic Chemistry (2024)
2024
7.
Sang, Y., Lee, R. H., Luong, A., Katona, É., Whyte, C. S., Smith, N. L., Mast, A. E., Flick, M. J., Mutch, N. J., Bergmeier, W., Wolberg, A. S.: Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation.
Blood Adv. 8 (19), 5072-5085, 2024.
Journal metrics:
D1 Hematology
8.
Katona, É.: A diagnosztikus tesztek fejlesztésének és validálásának szempontjai.
In: Klinikai kutatások : Átfogó ismeretek a tervezéstől a közlésig. Szerk.: Bereczky Zsuzsanna, Bagoly Zsuzsa, Katona Éva, Medicina Könyvkiadó Zrt., Budapest, 153-172, 2024. ISBN: 9789632269115
9.
Katona, É.: Az analitikus obszervációs klinikai tanulmányok típusai, tervezésük sajátosságai.
In: Klinikai kutatások : Átfogó ismeretek a tervezéstől a közlésig. Szerk.: Bereczky Zsuzsanna, Bagoly Zsuzsa, Katona Éva, Medicina Könyvkiadó Zrt., Budapest, 55-71, 2024. ISBN: 9789632269115
10.
Tóth, E. L., Orbán-Kálmándi, R. A., Bagoly, Z., Lóczi, L., Deli, T., Török, O., Deliné Molnár, S., Baráth, S., Singh, P., Hevessy, Z., Katona, É., Fagyas, M., Szabó, A. Á., Molnár, S., Krasznai, Z. T.: Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Front. Immunol. 15, 1-10, (article identifier: 1329236), 2024.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
11.
Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, (article identifier: 2893), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
12.
Pituk, D., Balogh, L., Horváth, E., Hegyi, Z., Baráth, B., Kissné Bogáti, R., Szűcs, P., Papp, Z., Katona, É., Bereczky, Z.: Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.
Int. J. Mol. Sci. 25 (21), 1-19, (article identifier: 11746), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
13.
Ghansah, H., Orbán-Kálmándi, R. A., Bekéné Debreceni, I., Katona, É., Rejtő, L., Váróczy, L., Lóczi, L., Laat, B. d., Huskens, D., Kappelmayer, J., Bagoly, Z.: Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Thromb. Res. 234, 12-20, 2024.
Journal metrics:
Q2 Hematology
2023
14.
Somodi, L., Horváth, E., Bárdos, H., Baráth, B., Pethő, D., Katona, É., Balla, J., Mutch, N. J., Muszbek, L.: Cellular FXIII in Human Macrophage-Derived Foam Cells.
Int. J. Mol. Sci. 24 (5), 1-12, (article identifier: 4802), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
15.
Katona, É.: Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII.
Thromb. Haemost. 123 (9), 855, 2023.
2022
16.
Raut, S., Katona, É., Riches-Duit, A., Coxon, C., Muszbek, L., Schroeder, V., Rigsby, P.: An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
J. Thromb. Haemost. 20 (2), 525-531, 2022.
Journal metrics:
D1 Hematology
D1 Medicine (miscellaneous)
17.
Székely, E. G., Orbán-Kálmándi, R. A., Szegedi, I., Katona, É., Baráth, B., Czuriga-Kovács, K. R., Lóczi, L., Molnárné Vasas, N., Fekete, I., Fekete, K., Berényi, E., Oláh, L., Csiba, L., Bagoly, Z.: Low [alfa]2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
Front. Cardiovasc. Med. 9, 1-14, (article identifier: 901286), 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
18.
Kissné Bogáti, R., Katona, É., Shemirani, A. H., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, (article identifier: 5845), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2021
19.
Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z. A., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203, 110-116, 2021.
Journal metrics:
Q1 Hematology
20.
Plamenova, I., Zolkova, J., Sokol, J., Kolkova, Z., Bereczky, Z., Katona, É., Muszbek, L., Kubisz, P., Staško, J.: Genetic Background of Inherited Factor XIII-A Subunit Deficiency: review of the Literature and Description of Two New Cases.
Semin. Thromb. Hemost. 47 (7), 885-889, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q1 Hematology
21.
Bagoly, Z., Baráth, B., Orbán-Kálmándi, R. A., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, (article identifier: 347), 2021.
Journal metrics:
Q2 Biochemistry
Q2 Molecular Biology
22.
Gindele, R., Pénzes-Daku, K., Balogh, G., Kállai, J., Kissné Bogáti, R., Bécsi, B., Erdődi, F., Katona, É., Bereczky, Z.: Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.
Biomolecules. 11 (4), 1-18, (article identifier: 544), 2021.
Journal metrics:
Q2 Biochemistry
Q2 Molecular Biology
23.
Potor, L., Hendrik, Z., Patsalos, A., Katona, É., Méhes, G., Póliska, S., Csősz, É., Kalló, G., Komáromi, I., Combi, Z., Posta, N., Sikura, K. É., Pethő, D., Oros, M., Vereb, G., Tóth, C., Gergely, P., Nagy, L., Balla, G., Balla, J.: Oxidation of hemoglobin drives a proatherogenic polarization of macrophages in human atherosclerosis.
Antioxid. Redox Signal. 35 (12), 917-950, 2021.
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
D1 Clinical Biochemistry
D1 Medicine (miscellaneous)
Q1 Molecular Biology
D1 Physiology
2020
24.
Bovet, J., Hurják, B., Maistre, E. D., Katona, É., Pénzes-Daku, K., Muszbek, L.: Autoimmune Factor XIII Deficiency With Unusual Laboratory and Clinical Phenotype.
J. Thromb. Haemost. 18 (6), 1330-1334, 2020.
Journal metrics:
Q1 Hematology
D1 Medicine (miscellaneous)
25.
Hurják, B., Kovács, Z., Döncző, B., Katona, É., Haramura, G., Erdélyi, F., Shemirani, A. H., Sadeghi, F., Muszbek, L., Guttman, A.: N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence.
J. Thromb. Haemost. 18 (6), 1302-1309, 2020.
Journal metrics:
Q1 Hematology
D1 Medicine (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen